The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease

被引:76
作者
Palmer, AM
机构
[1] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA
关键词
antioxidant; dementia; free radicals; glutathione; human brain; neurodegeneration;
D O I
10.1007/s007020050161
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In order to assess the integrity of antioxidant enzymes in Alzheimer's disease, the activities of glutathione peroxidase, glutathione reductase and two enzymes of the pentose phosphate pathway (glucose-6-phosphate dehydrogenase and 6-phosphonogluconate dehydrogenase) were determined in three regions of postmortem neocortex of controls and subjects with Alzheimer's disease. The activities of glutathione peroxidase and glutathione reductase were unaffected in Alzheimer's disease. By contrast, there was a selective increase in the activities of glucose-6-phosphate dehydrogenase and 6-phosphonogluconate dehydrogenase in the inferior temporal cortex of Alzheimer subjects. These changes negatively correlated with the Fe2+/ascorbate-induced lipid peroxidation which (in a previous study of the same subjects) was also found to be selectively elevated in the inferior temporal cortex. Increased activity of the pentose phosphate pathway probably occurs in response to increased prooxidant activity since both glucose-6-phosphate and 6-phosphonogluconate inhibited H2O2-induced lipid peroxidation in a concentration dependant fashion (IC50 = 504 +/- 105 mu M and 88 +/- 12 mu M, respectively). Together, these data suggest that not only is oxidative stress a feature of Alzheimer's disease, but also that it occurs because of increased prooxidant activity rather than a diminished antioxidant capacity.
引用
收藏
页码:317 / 328
页数:12
相关论文
共 55 条
[1]   Ascorbate-stimulated lipid peroxidation and non-heme iron concentrations in Alzheimer disease [J].
Andorn, AC ;
Britton, RS ;
Bacon, BR ;
Kalaria, RR .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1998, 33 (01) :15-26
[2]   EVIDENCE OF AN OXIDATIVE CHALLENGE IN THE ALZHEIMERS BRAIN [J].
BALAZS, L ;
LEON, M .
NEUROCHEMICAL RESEARCH, 1994, 19 (09) :1131-1137
[3]  
BEUTLER F, 1984, RED CELL METABOLISM, P68
[4]  
BOWEN DM, 1979, LANCET, V1, P11
[5]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[6]  
Cohen G., 1988, OXYGEN RADICALS TISS, P130
[7]  
COTGREAVE IA, 1988, ANNU REV PHARMACOL, V28, P189
[8]   USE OF A MICROPLATE READER IN AN ASSAY OF GLUTATHIONE-REDUCTASE USING 5,5'-DITHIOBIS(2-NITROBENZOIC ACID) [J].
CRIBB, AE ;
LEEDER, JS ;
SPIELBERG, SP .
ANALYTICAL BIOCHEMISTRY, 1989, 183 (01) :195-196
[9]   Oxidative mechanisms in beta-amyloid cytotoxicity [J].
Davis, JB .
NEURODEGENERATION, 1996, 5 (04) :441-444
[10]  
DEKOSKY ST, 1992, ANN NEUROL, V32, P625